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11 If you can look into the seeds of time 
and say which grains will grow and which will not II 
(William Shakespeare - Macbeth i.iii.) 
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1. 
1. INTRODUCTION 
"The induction phenomenon is a useful model for the study of . 
mechanisms which regulate the synthesis of specific enzymes 
in mammalian tissu~, as well as for the role of hormones in 
this process" (1). The in vivo administration of hormone 
initiates a chain of reactions which culminate in the increase 
of protein synthesis (2). Many hepatic enzymes are thus 
affected (3) resulting in an increase of their activity 
(1,4,5). 
Studies of the giant chromosomes in the salivary glands 
of Chironomus tentans provided the first indications that the 
earliest intracellular effects of hormone administration are at 
the genetic level (290). Injection of the insect moulting 
hormone, ecdysone, into last instar larvae of Chironomus tentans . 
. results in puff formation at specific loci of the chromosomes 
shortly after hormone administration (291,292). Since puffs 
are local and reversible alterations of the chromosome, formed 
at sites which are active in the synthesis of informational RNA 
(137,293,294), their formation shows a change in activity of 
particular gene loci in response to ecdysone. 
Alterations in the chromatin of various target tissues 
(6-8) frpm the inactive heterochromatic (9,10) to the active 
euchromatic (8,10,11) condition, and increases in their template 
capacity for the DNA dependent RNA polymerase reaction after 
hormone treatment (12-16) have since been described. In 
addition, the polymerase enzymes themselves are stimulated -
++ 
both the nucteolar (17-2l) Mn - dependent and the extra-nucleolar 
(22-26) Mg++~ dependent enzyme species, which catalyze the . 
synthesis of DNA-like RNA (AU rich) (27) ) (28) and ribosomal 
RNA (GC rich (27) ) (29-33,14) respectively. 
A further effect of hor~one administration is the alteration 
of the microstructures of histones by acetylation (34,35) 
phosphorylation (36-39) and methylation (35,41,88). These basic 
chromosomal proteins (42) are closely associated with DNA 
in the chromatin (43,58) and their possible role as genetic 
repressors has been extensively discussed (44-47). DNA 
complexed with histone is not effective as a template for the 
DNA dependent RNA polymerase catalyzed synthesis of RNA 
(transcription) (43,48-51), and histones inhibit this reaction 
in vitro (52,53). 
2. 
Which histone fraction is the most effective inhibitor remains 
a controversial subject (53-56). Spelsberg et. al. (57) have 
described the interaction between the RNA polymerase enzyme and 
different histone fractions. In their opinion, the lysine-rich 
histones have their effect by direct template repression, while 
arginine-rich histones decrease transcription by inactivation of 
the enzyme itself (50,51). The interaction between histones. 
and DNA is electrostatic in nature (42,52,59,104), and any 
modification ~f the microstructure of these proteins which affect 
their basicity, results in a change of their affinity for DNA (46). · 
Depending on the type of modification, this ~ay be followed by 
a partial (60) or total (61) release of histone rendering the 
genetic material available for transcription (46,62). 
Acetylation and phosphorylation reactions cause a decrease 
in the positive charge on the histone molecules and hence 
their release (46,60-62); methylation, however, raises the 
positive charge and effects a stronger binding between histone 
and DNA (63). The enzymatic modifications (47,53) of these 
proteins lead to structural alterations on or hear ·potential 
DNA binding sites (61,64-67). Transacetylases, which 
catalyse the transfer of the acetyl group of acetyl co-enzyme A 
(68,69) to the E-amino groups of internal lysine residues 
(41,70) of histones have been isolated from the nuclei of 
various organisms (41,65,68,71-75). Protein kinases (76-80) 
have been found which phosphorylate all histone fractions 
(81-84) to varying extents (46,83,85) ~t the NH2-terminal serine 
residue (36,61,81,86) and at serine and threonine residues in 
the -COOR-terminal region (61,87). Methylated lysine ($8-90), 
histldine (88,91) and arginine (40) residues of histones have 
been identified; each amino acid residue appears to be 
methylated by a diffe~ent enzyme · (92-94) although S-adenosyl-methionine 
is the common methyl donor (95-97). Enzymes which specifically 
remove these groups from the modified residues have been isolated 
(98,99). 
None of the above alterations involve de novo synthesis of 
histone (72,95,97) - the processes are insensitive to puromycin 
(97) and do not occur at the time of amino acid incorporation into 
new histone (100,101). Because of the uptake into histone and the 
turnover of these groups in vivo at specific .times in the cell cycle 
(37,102,289) their effects on histone have been correlated with the 
transcriptional level control (43-45,48,103) of genome activity. 
' 
4. 
Histones complex with corticosteroid hormopes in vitro 
(149-155) (the arginine-rich fractions being more effective 
than the lysine-rich fractions (149-151,156) ) and thereby 
alter the template capacity of the associated DNA (16,151,157, 
158). Some workers have found in vivo injected labelled 
hydrocortisone bound · to histone (16,151,156,158), others have 
not (149,159). Tsai and Hnilica (149) associate this in vivo 
binding with contaminating cytoplasmic material in the 
isolated histone preparations. Polyamines have been reported 
to affect the accumulation of newl~ synthesized RNA in whole cells 
and in nuclear and nucleolar preparations in vitro (160,287). 
The role of the polyamines in the stimulation of RNA synthesis 
has not been elucidated. 
From the accumulated evidence concerning the hormone-mediated 
derepression of the genome, the primary action of the hormone 
is thought to be at the transcriptional level (161). One 
of the early responses to such stimulation is the increased · 
synthesis of all types of RNA in the nucleus (162-164). 
The production of messenger RNA is suggested by the ensueing 
protein synthesis (32) - which is sensitive to such DNA-binding 
drugs (165-168) as Actinomycin D (162,169,170). Sequentially, 
the precursor ribosomal RNA's (171-174,33) (which mature 
into the characteristic 30S and 18S ribosomal ~A's· (164,174, 
175) ) appear in advance of the transfer RNA's and the DNA-like 
species (15,176,177), suggesting ·an initial activation of the 
A-T rich regions of the genome and a slightly later derepression 
of the GC-rich regions. 
---The newly synthesized RNA's are transported to the site of 
protein synthesis in the cytoplasm (24,178-180). Hormones 
may be involved also in this phase of enzyme induction by 
facilitating the transport of RNA across the nuclear membrane . 
(181,182,296) . • 
Whichever the mechanism(s) involved, the observed effects of 
hormone in tar,.get tissues, are the increases of RNA synthesis 
. ~ 
followed by the increases in protein synthesis. 
In this study an attempt has been made to obtain information 
on the timing of enzymatic histone modification in the course 
·of events occurring as a response to hormone administration 
in vivo. 
3. 
Alterations in the binding of histone to DNA have also 
been related to the interaction of non-histone chromosomal 
proteins (NHC proteins) both with histone (104) and DNA 
(35,105,106). These NHC proteins have been suggested as 
regulatory intermediates in the restriction of DNA template 
activity by histone (107-112,130). The binding of these 
acidic proteins (111~113,114) to DNA is both species 
(35,105,106) and organ (115,120,130) specific, and their complexes 
with histone render the latter inactive as inhibitors of RNA 
synthesis (109,110,121-124). The NHC proteins themselves have 
been shown by some authors to be ineffective in this repression 
(110,116,119). Other workers, however, have found them capable 
1. of inhibiting the RNA polymerase reaction to a limited extent 
(117,118). Johnson et. al. (125) have noted a restriction of 
DNA template activity early in sea urchin development before 
the first histones are synthesized. 
Chromatin of a given organism, with a high template activity, 
contains more NHC proteins than does chromatin with low template 
activity (52,126-131). In response to hormone treatment 
(110,132-134) target cells accumulate both RNA and NHC proteins 
(135-139). In labelling experiments the specific activities 
of the latter are proportional to the synthesis of DNA-like RNA 
(140). The RNA synthesized using chromatin from different organs 
as a template shows organ specificity (108). The artificial 
reconstruction of such chromatin using DNA and NHC protein 
from different organs results in hybrid chromatins; If 
these hybrid chromatins are used as templates, the organ 
specificity of the RNA synthesized is determined by the parent 
-----
organ of the NHC proteins (107,108,141). 
Anothe_r candidate for conferring specificity of repression 
on histones is the chromosomal RNA of Bonner et. al. (142,143). 
Other workers have been unable to confirm Bonner's results 
and suggest that this species is a contaminant transfer RNA 
(144-146). Hormone induced modifications of the DNA molecule 
itself have be§n described (133,147,169) whereby its capacity for 
histone binding becomes reduced (79,148). 
\ 
5. 
1. 2. PLAN OF RESEARCH 
A severe lack of information exists concerning time correlation 
between gene. activation, enzymatic histone modification, RNA 
synthesis and the ensueing protein synthesis, investigated 
in one experimental model. Many investigations have been 
reported combining any two of these four processes. The 
induction -0f enzyme activity by steroid (3,4,183-185) and 
polypeptide (2,4,186) hormones is well documented. That' 
template activation and RNA synthesis precede protein synthesis 
is an established fact. Histone modification by acetylation (187-189) and phosphorylation (37,38) appears to occur in 
advance of template activation and RNA synthesis (190,65), 
while methylation appears to be a relatively late event 
(191,63). The general picture arising from the available 
information, gained from many different experimental systems, 
seems to show that derepression of the genome involves acetyl-
ation and phosphorylation of arginine-rich histones, and an 
elevated rate of RNA synthesis, followed by an increase iri 
protein synthesis and methylation of most fractions of histone. 
To verify this general tentative view on the process of 
derepression, a detailed study of the time course of these 
events under jdentical experimental conditions is necessary . 
As inducers of enzyme activity, the hormones hydrocortisone 
and insulin were chosen. Both were known to increase the 
activity of hepatic tyrosine transaminase, L-tyrosine-2-
oxoglut~te-aminotransferase EC 2. 6 .1. 5 (TAT*) (2-4) . This 
increase is due to increased de novo synthesis (1,4,5) and 
not to decreased degradation (192,193). The enhanced 
transaminase activity resulting from steroid or insulin 
stimulation can therefore serve as a satisfactory model to 
investigate the process of induction. The following parameters 
have been examined: time course of enzyme activity, of RNA 
synthesis, and of histone modification by phosphorylation, 
acetylation and methylation during induction with hydro-
cortisone and insulin. 
* TAT - abbreviation Tyrosine aminotransferase. 
6. 
2. MATERIALS 
All chemicals used were of Analar grade or equivalent 
supplied by various companies. 
Radioactive chemicals were obtained from the Radio-
Chemical Centre, Arnersham, England. 
Tyrosine labelled in ·the c1 position was not commercially 
available, and was therefore synthesized. 
2 .1. SYNTHESIS OF TYROSINE - 1 4 COOH 
c1 labelled amino acids can be synthesized according to 
the following reaction: 
L-Ty~osine 
DL-Tyrosine- 14 COOH 
-----> HOo· -CH -CHO ·· 2 ' . 
p-hydroxy-phenyl-acet~ldehyde 
'I/ 
EtOH 
6 
HO-o-CH -HC- 14 ~ 2 I I 
HN NH 
HCl 
' / 
C 
II 
0 
4- 14 C~p-hydroxy-benzyl-hydantoin 
Various attempts to prepare the p-hydroxy-phenyl-acetaldehyde 
via oxidative decarboxylation and deamination of tyrosine with 
ninhydrin in order to prepare the 4- 14 C-p-hydroxy-benzyl-hydantoin 
as intermediate for the synthesis of carboxyl labelled tyrosine 
failed. 
Figure 2.1. is a schematic representation of the method 
finally employed (194). 
• 
7. 
Figure 2.1. SCHEMATIC REPRESENTATION OF THE~THOD USED FOR 
THE SYNTHESIS OF TYROSINE- 14 COOH 
CHO HC - CH - COONa Cl-CH2 ::,COOC2H5 0 Ethyl chloroacetate CH -O-Na I 3 
0 CH -CH -O-Na 
I 3 2 
CH 3 
Anis aldehyde 
1 4 COOH 
I 
H~ - NH2 
CH 2 I HC.l 
I '0/ 
> 0 
I 
0 
I 
CH 3 
Glycidate 
0 <·----------
I 
OH 
DL-Tyrosine- 14 COOH 
----
D-arnino acid 
!::. 140 ·- 160°C 
oxidase 
NaHS03 
6 
I 
0 
I 
CH 3 
Bisulphite compound 
0 H 
14C-N 
V 
K 1 4 CN 
I ' CH-N-C = O 
I H 
?H2 
0 
I 
0 
I 
CH 3 
Hydantoin 
37°c Catalase 
4 hrs 
02 
V 
1 4 COOH 1 4 COOH 
I I . 
NH 2 - CH + C = 0 + NH 3 I 
7H2 7H2 
0 () 
I I OH OH 
8. 
2. l.i. p-methoxy-phenyl-acetaldehyde sodium bisulphite compound 
7 g Sodium were dissolved in 50 ml absolute ethanol and 
50 ml absolute methanol, and cooled. 
The sodiurn-ethylate, sodium-methylate mixture was added to a 
solution of 32.0 ml ethylchloroacetate, 36.5 ml anisaldehyde in 
70 ml anhydrous ether at a rate whereby, with salt-ice cooling 
and continuous sitrring, the temperature was maintained at 2°c. 
When all the sodium alcoholate had been added, cooiing was 
discontinued, and the mixture allowed to reach room temperature. 
It was then poured into 650 ml cold distilled water. The 
aqueous solution was extracted 5 times with 100 ml portions of 
ether. The ether extract, washed with 300 ml cold water, 
300 ml cold 3% NaHC03 and again 300 ml cold water, was chilled 
and poured with constant stirring into an ice-cold solution of 
6. 9 g sodium in 100 ml me~thanol and 6. 0 ml water. 
The sodium p-methoxy-phenyl-glycidate which precipitated from 
the mixture at 4°c within ten minutes was collected by 
filtration with suction. It was washed with 10 ml methanol~ 
50 ml ether, and 40 ml ethanol - 30 ml water, and then added to 
a vigorously s~irred solution of 70 g NaHS0 3 in 250 ml boiling 
water. The pH was brought to about 4.5 by addition of 8 ml 100% 
acetic acid and the solution allowed slowly to cool to s0 c. 
_The resulting heavy precipitate of p-methoxy-phenyl-acetaldehyde 
sodium bisulphite compound was collected by centrifugation and 
stored until use at -14°c. 
2. l.ii. S(p-methoxy-benzyl) Hydantoin-4- 14 C 
600 mg Bisulphite compound 
600 mg (NH 4 ) 2co 3 (powdered) 
64 mg KCN 
1 m 
1 mg (O. 6 mCi) K1 4 CN (39.6 mCi/rnM) 
3.0 ml 50% EtOH-H20 (v/v) 
were heated in a sealed ampoule for 4 hours at 100°c. 
After the tube had been cooled and opened, the mixture was 
mole 
0 gradually warmed to 104 C to decompose excess (NH 4 ) 2co3 and remove the ethanol. 3.0 ml hot water was added, and the mixture was 
transferred to a centrifuge tube and cdoled for a minimum of 
2 hours. 
9 • 
The hydantoin precipitate was collected by centrifugation, 
heated in 50% ethanol-water (v/v) until ·it dissolved, transferred 
to an ampoule and cooled to room temperature. It was then dried 
by gentle heating (5o0 c) under a stream of nitrogen. 
2. l.iii. 14 C-Carboxyl-labelled DL-Tyrosine 
The hydantoin was heated in the sealed. ampoule with 3.0 ml 6 M 
distilled hydrochloric acid for 4 hours . from 140°c to 160°c. 
The tube was cooled and opened. 3.0 ml water were added to the 
contents which was then heated in a water-bath and treated hot 
with charcoal. The solution was neutralised with ammonium 
hydroxide to pH 6 and transferred to a centrifuge tube for 
cooling. 
The resulting brownish precipitate was washed with cold water 
(until these washes no longer showed a positive reaction with 
Nessler's Reagent), cold ethanol and cold ether and finally dried 
over clacium chloride yielding white crystals of DL-tyrosine- 14 COOH 
with a speci fj. c activity of 0.56 µCi/µmole . (Total yield 
based on K14 CN = 50%). 
This radioactive DL-tyrosine had an UV absorption spectrum and 
molar extinction coefficient identical to commercial tyrosine, 
and the determination of a-amino groups by the ninhydrin method of 
Troll and Cannon (195) gave 97% the theoretical value. 
Thin layer chromatography using 96% ethanol-water (7:3 v/v) 
as mobile phase yielded a single ninhydrin positive spot with the 
---Rf value of tyrosine, and no additional organic components could 
be detected after exposure of the chromatogram to iodine vapour. 
The radioactivity was confined to the ninhydrin positive fraction, 
though large excesses of tyrosine rad been applied to the 
chromatogram in order to detect contaminations (Figure 2.2.). 
All radioactivity of a solution of the l- 14 C-tyrosine preparation 
+ 
was adsorbed by a Dowex 50(X4) H column. Extensive washing of 
the column with water rE~moved none of the adsorbed activity, 
whereas 1 N NH 40H released all the radioactivity. 
"' 0 
r-1 
X 
10. 
Figure 2.2. THIN LAYER CHROMATOGRAPHY OF DL-TYROSINE- 14 COOH 
I 
1< 3.4 ---
1 
1(-- 2. 3 --;:,. 
I 
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1 Distance from fluid front (cm) 
., 
, Fluid front 
I\ 
3 cm Centre portion 
cut out for 
counting . 
<=======---
Direction of chromatography 
Development with 96 % ethanol-water (7:3 v/v), 60 minutes. 
A centre portion was cut out and divided into 0.5 c m 
strips; the radioactivities of which were determined. 
The rema-blder was stained with 0.1% Ninhydrin in acetone. 
11. 
2. l.iv. 14 C-Carboxyl labelled L-Tyrosine 
Pure L-tyrosine- 14 COOH was prepared from the DL-tyrosine- 14 COOH 
by enzymatic destruction of the D-isomer with D-amino acid 
oxidase (196) according to the following reaction: 
R-CH-COOH + H2 0 I 
NH2 
(~mino acid) 
D-amino acid oxidase 
Catalase 
> R-C-COOH + NH 3 + H2o2 
" 0 
(Keto acid) 
The incubation mixture in a total of 34 ml, contained the following 
26.997 µmoles DL-tyrosine- 14 COOH in phosphate buffer pH= 7.1 
(= 13.267 µmoles D-isomer) 
13.3 U D-amino acid oxidase (EC 1.4.3.3. Boehringer crystalline 
suspension in 1.8 M (NH 4 ) 2so4 solution, pH= 6.5; 5 mg/ml 
15 U/mg). 
19,500 U CatalaS~ (EC 1.11.1.6 Boehringer crystalline suspension 
in thymol saturated water pH= 6.0; 20 mg/ml 39,000 U/mg). 
5.0 ml 0.1 M Sodium pyrophosphate-hydrochloric acid buffer pH= 8.3. 
The mixture was incubated for 4 hours at 37°c in a water-bath with 
continuous shaking, and oxygen passed through the solution through 
a . sintered glass filter stick. Thereafter the contents of the 
incubation . flask was freeze-dried, the resulting material taken 
up in 9 ml distilled water, and applied to a 10 ml column of 
Dowex 50 (X4) H+. 
The water eluent containing the keto acid arising from the D-isomer 
was collected until no further radioactivity emerged. The 
combined fractions yielded 40% of the total activity incubated 
with the oxidase enzyme. Amino acid was eluted with 2 N ammonium 
hydroxide (48% of totai activity), the combined fractions freeze-
dried and the dry material taken up in 20 ml pH 7.1 phosphate 
buffer. 
The ratio of 14 c keto acid/ 14 C amino acid indicated incomplete 
removal of the D-isomer. This solution was therefore re-
treated with oxidase and subsequently processed under the same 
incubation conditions as described above. 
12. 
A small amount (6 %) wa s r e cove red as ke t o acid in the wa ter 
eluent and 90% as amino acid in the ammonium hydroxide eluent. 
The latter was freeze-dried as the material still contained 
denature d enzy me protein, suspended in 3 ml distilled wa~er, and 
t h e tyrosine dialysed out into 6 changes of 5 ml water. 
Th is final L-tyrosi~e- 14 COOH solution had a specific activity of 
0.54 µCi/µrnole. 
• 
3. METHODS 
3.1. TYROSINE TRANSAMINASE 
3.1.1. Principles of TAT Assay 
13. 
The transaminase reaction is the pyridoxal phosphate 
dependent transfer of the a-amino group of tyrosine from the 
amino acid to the C2 position of the acceptor molecule, 
a -keto glutaric acid. The co-enzyme reacts with tyrosine 
to form a Schiff base from which p-hydroxy-phenyl-pyruvic acid 
is released; the remaining pyridoxamine phosphate then reacts 
with a-keto glutaric acid to form a second Schiff base which 
hydrolyses yieloing g'iutamic acid and the restored co-enzyme. 
The overall reaction may be written : 
COOH 
I 
NH - CH 2 I 
CH2 
I 
0 + 
I 
OH 
Tyrosine 
COOH 
I 
(CH2)2 TAT 
I 
C = 0 Pyridoxal 
I phosphate 
COOH 
a-Keto glutaric 
acid 
> 
COOH 
I 
C = 0 
I COOH CH2 I I (CH2)2 
I 0 + NH2 - CH 
I 
OH 
Keto acid 
(p-hydroxy-phenyl-
pyruvic acid) 
I 
COOH 
Glutamic 
acid 
Assay methods for this enzyme would entail a) measurement of 
the keto acid formed, orb) measurement of the unreacted 
substrate remaining after the enzyme reaction. 
a) The assay method of Tomkins et. al. (197) involves the 
alkali-catalyzed oxidation of p-hydroxy-phenyl-pyruvic acid by 
molecular oxygen to p-hydroxy-benzaldehyde and oxalate. The 
extinction at 331 mµ of p-hydroxy-benzaldehyde is taken as a 
measure of keto acid product formed. In our attempts to apply 
this assay, considerable difficulties were encountered, largely 
because of the limited stability of the aldehyde, and the 
difficulties to clearly identify spectrophotometrically the small 
amount of p-hydroxy-benzaldehyde in the presence of a large excess 
of tyrosine. 
14. 
The method of McFarlane (198) for the assay of leucine transaminase 
is based on the decarboxylation of the l- 14 C-keto acid arising 
out o f the transamination of l- 14 C labelled amino acid. The 
decarboxylation is achieved through the reaction of the keto acid 
with eerie sulphate (Ce(so4 );, yeilding labelled co2 which is a 
measure of the keto acid formed during the transamination reaction. 
Attempts to apply this method for the assay of tyrosine trans-
aminase were unsuccessful. Though the Ce(so4 ) 2 decarboxylation 
is considered to be specific for a-keto acids under the conditions 
applied (199) and has been shown to be a-keto acid specific in 
the leucine transaminase test, it was found that l- 14 C-tyrosine 
also underwent decarboxylation by Ce(S04 ) 2 • 
b) An alternative would have been to decarboxylate unreacted 
tyrosine after the enzyme reaction had been terminated, and, as 
above, to collect and count the co2 produced. However, attempts 
to decarboxylate unreacted tyrosine quantitatively with n1nhydrin 
both in citric acid medium (200) and organic medium (195) also 
proved unsuccessful under the conditions required. 
A new method of assay was thus developed based on the following 
principle ; unutilized substrate (a-amino acid) at the end of 
the reaction was bound onto Dowex (X4) H+ cation exchange beads, 
the unbound radioactive keto acid removed by exhaustive washing 
with water, and the amino acid finally released from the ion 
exchange resin with ammonium hydroxide. The radioactivity of 
this solution was then determined. Enzyme activity (micromoles 
tyrosine consumed) corresponded to the difference between total 
14 C activity at zero time and ion exchanger-trapped radioactivity 
at the end of the experiment. 
3. 1. 2. TAT Assay Method 
(1) Preparation of Crude Extract (197) 
After a standard period of 20 hours fasting, experimental 
animals were stunned by a blow on the head, decapitated and 
exsanguinated. The livers were rapidly exicsed, and homogenized 
in 3 x volume of ice-cold 0.15 M KCl containing 10- 3 M EDTA 
adjusted to pH = -7.6 with sodium phosphate, in a glass homogenizer 
with teflon pestle. The homogenate was centrifuged at 
20,000 x g for 30 minutes at 4°c in a Sorvall RC 2 centrifuge 
and the resulting sediment discarded. 
natant were used as enzyme extract. 
Aliquots of the super-
( 2 ) Assay 
15. 
The incubation mixture contained 
0.1 µmole pyridoxal phosphate 
9.0 µmoles a -keto glutarate (di-sodium salt 
adjusted to pH= 7.6) 
1. 0 µmole EDTA 
13.4 µmoles tri-ethanol-amine 
0.0346 µmoles 14 C-tyrosine (62 µg/ml aqueous 
solution adjusted to pH= 7.6 with di-sodium 
phosphate) 
1.2 µmoles carrier L-tyrosine (dissolved in 
phosphate. buffer pH= 7.6) 
which, together with the enzyme extract, made up a total volume 
of 1.8 ml pH= 7.3. Addition of extract initiated the reaction 
and, in initial experiments, incubation continued with shaking 
for 15 minutes at 37°c. The reaction was at first terminated 
by heating the incubation mixture at 100°c in a boiling 
water-bath for 2 minutes. However, termination by addition 
of the ion exchanger resulting in an immediate drop of pH, 
proved a more reliable method. The solution was allowed to 
exchange with 500 mg Dowex H+ beads for a standard period of 
10 minutes after which time the supernatant fluid was drawn 
off with a finely-tipped Pasteur pipet. The beads were 
washed with 2 x 2.0 ml distilled H2o, and the absorbed 
unreacted substrate released by elution with 2.0 ml 1 N 
ammonium hydroxide . 0.4 ml Aliquots of the NH 40H super-
natant were taken for radioactivity determinations. 
For the TAT reaction to proceed, a-keto glutaric acid is an 
essential -component of the incubation mixture, whereas 
oxidative deamination can proceed in the absence of a keto 
acid acceptor. To exclude the presence of contaminating 
L-amino acid o~idase activity in the extract, experiments 
including and excluding a-keto-glutarate were carried out. 
In the absence of acceptor keto acid, 15 minutes incubation 
yielded 100% recovery of radioactivity as amino acid, 
indicating the absence of an oxidative deamination reaction. 
16. 
Under identical conditions, in the presence of 4.5 x 10- 3 M 
and 9 x 10 3 M a-keto glutarate, 35% of the -substrate was 
consumed. a-Keto glutarate was therefore limiting for the 
activity assayed,.ruling out the possibility of contaminating 
amino acid oxidase. 
L-tyrosine has a solubility of only 0.453 mg/g H2 o at 25°c (201} 
o~ 2.5 µmoles/ml, just allowing substrate saturation conditions 
(Figure 3.1). However, the amount of tyrosine that could be 
included within the assay volume was seriously limited. This 
led to a rapid depletion of substrate unless the amount of 
enzyme was kept very low and the incubation temperature reduced 
from the initially used 37°c, to 25°c. The reaction rate 
was linearly dependent on the amount of enzyme extract at 
10 minutes incubation, up to an extract volume of 0.2 ml 
(Figure 3.2). Attempts to increase the amount of substrate 
by saturating the assay volume with tyrosine led to uncontrollable 
inaccuracies. The TAT assay therefore has inherent limitations 
which may lead to an under-estimation of high enzyme activities~ 
After establishing these properties of the assay system, the 
following standard procedure was adopted : 
The incubation medium as described above, total volume of 
1.775 ml pH= 7.6, and a tyrosine concentration of 0.7 x 10 3 M 
(total activity 40,000 dpm 14 C} was equilibrated t o· 25°c in 
a water-bath. Addition of 0.025 ml enzyme extract initiated 
the reaction, incubation was carried out with shaking at 25°c 
for 10 minutes, and the reaction stopped by addition of 500 mg 
Dowex H+ beads to the incubation mixture. After 10 minutes 
----mixing with a magnetic stirrer, the beads were allowed to settle, 
a further 500 mg Dowex beads were added and the mixing repeated. 
A standard period of 5 minutes was maintained to allow all the 
beads to settle before the supernatant fluid was drawn off, and 
the beads washed with 2 x 2.0 ml distilled H2o. The absorbed 
tyrosine was eluted with 2.0 ml 1 N NH 40H. Aliquots were counted 
in 10 ml of scintillation cocktail. TAT activity was expressed 
in µmoles tyrosine transaminated per mg protein per 10 minutes. 
17. 
Figure 3. 1. Substrate dependence of TAT Assay 
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Protein was determined by a Biuret method (202); µmoles 
tyrosine transaminated were calculated from the equation: 
radioactive tyrdsine added (dpm) - radioacti~ tyrosine recovered (dpm) 
specific activity of substrate (dpm/µmole) 
Enzyme extracts were assayed immediately after preparation as 
freezing of the extract for storage and subsequent thawing resulted 
in variable loss of activity. 
3. 2. ISOLATION OF RNA 
3. 2. 1. ISOLATION PROCEDURE 
Various methods were investigated: 
i) The method of Kirby (203) for the preparation of total 
RNA from rat liver proved unsuitable for the purpose of this project. 
RNA samples prepared by this method, which involved sodium dodecyl 
sulphate treatment and hot phenol (6o0 c) extraction, sedimented 
on sucrose gradients (see 3.2.2) as a single band with an S value 
of approximately 10. Gel filtration on sephadex G25 also showed that 
this preparation consisted largely of, probably degraded, low 
molecular weight RNA. 
ii) Ribosomal RNA was isolated by the method of Moldave et. al. 
(204). The crude ribosomes (205) were treated with sodium 
dodecyl sulphate, and phenol extraction performed at 4°c. The 
ethanol precipitate from the combined aqueous phases was dissolved 
in potassium acetate and the RNA reprecipitated with cold ethanol. 
Sucrose gradient centrifugation of these samples yielded the 
characteristic RNA peaks at 18S and 30S and, in addition, a minor 
low molecular weight peak at approximately 4S. There was, 
___.... 
however, a contaminant nuclease activity which reduced the RNA 
peaks to half within one week. 
iii) A satisfactory isolation procedure for ribosomal RNA 
and 'rapidly labelled' RNA, giving stable preparations, was found 
in method 2 of Kirby (206). 
I ce-cooled livers were homogenized in a mixture of 15 volumes each 
of sodium 4-amino salicylate (6 % w/v), sodium chloride (1 % w/v), 
and a phenol cresol mixture (500 g phenol, 70 ml m-cresol, 
55 ml H2o, 0.5 g 8-hydroxy quinoline). 
19. 
The suspension was stirred for 60 minutes at room temperature. The 
aqueous phase, after 30 minutes centrifugation at 600 x g, was 
treated with solid NaCl (3 g/100 ml aqueous phase) and 0.5 volume 
of the phenol-cresol mixture at room temperature for 20 minutes. 
The mixture was centrifuged at 8,000 x g for 15 minutes and the 
resulting aqueous phase mixed with twice its volume of ethanol-cresol 
(9:1 v/v) and allowed to . stand at 4°c for 60 minutes (or overnight). 
The precipitate was centrifuged off and extracted twice with 
cold 3M potassium acetate pH= 6.0. This removed glycogen, 
DNA and most of the sRNA. The ribosomal RNA remaining insoluble 
under these conditions, was spun down each time at 8,000 x g for 
15 minutes . The final precipitate was washed once with a cold 
solution of NaCl (1% v/v) in ethanol-water 3:1 (v/v), followed 
by one wash with ethanol-water 3:1 (v/v) and finally two with 
ethanol. The resulting RNA precipitate was taken up in 
0.1 M NaCl - 10- 3 M EDTA buffered to pH= 6.2 with sodium hydroxide 
(207). RNA concentrations were determined from absorption 
readings at 260 mµ using the extinction coefficient 
E 
1 mg/ml 
260 mµ 
= 24. 
Samples were diluted to appropriate concentration for application 
to sucrose gradients (3.2.2) and polyacrylamide gels (207). 
The molecular weight distribution of these RNA samples was 
identical to that of samples isolated by the method of Moldave 
(204), and no nuclease activity was found in these preparations. 
3. 2. 2. SUCROSE GRADIENT CENTRIFUGATION 
Linear sucrose gradients, 5 - 20% (w/v) in 0.01 M acetic acid -
0.1 M sodium chloride adjusted to pH= 5.0 with sodium hydroxide 
-were prepared according to Kriih (208). Gradients were allowed 
to stabilize in the centrifuge tubes for 30 minutes at 4°c before 
application of 25 µl (75 µg) RNA samples. The tubes were 
centrifuged·at 35,000 rpm (100,000 x g) for 3~ hours at 3°c 
in a SW 50 swing bucket rotor of the Spinco Model L Ultracentrifuge, 
removed from the rotor and positioned on an Isco Model 180 Density 
Gradient Fractionator. The tubes were punctured approximately 
0.7 cm from the bottom with a BD22 syringe needle through which 
the 50% sucrose chase solution was provided to force the gradient 
upwards through the flow cell of the UV Analyzer. 
.. 
20. 
Figure_ 3. 3. TYPICAL PATTERN OF RIBOSOMAL RNA FRACTIONATED 
BY SUCROSE GRADIENT CENTRIFUGATION 
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5-20% Sucrose gradients (w/v) were centrifuged at 100 000 x g for 3\ hours and fractionated on the density gradient fractionator (see 3.2.2). The density gradient fractionator and the recorder were run at constant speeds viz. 0.5 ml/min. and 5 ,mm/min. respectively. 1 cm on the recorder qraoh therefore ean;:ils l ml r.F t-ho ...,..,..=-~; 0 ,..~ 
21. 
A standard speed of 0.5 ml/minute was maintained on the fractionator 
and 5 mm/minute on . the Metrohm Labograph E478 Recorder. The 
UV Analyzer was set at 254 mµ with a maximum scale of O - 1.0 OD. 
The rising meniscus of the top of the gradient caused an 
artefact peak which was due to a change of diffraction, and was 
conveniently taken as the beginning of gradient on the recorder 
graph. Similarly, the meniscus of the 50% sucrose chase 
solution caused another such peak at the end of the gradient. 
Optical density readings were taken directly from the recorder 
graph, and when radioactive samples were being handled, fractions 
emerging from the flow cell were collected directly into 
scintillation vials. As the density gradient fractionator 
forces the gradient upwards at a constant rate of 0.5 ml/minute, 
fractions were collected on a time basis - 30 second/sample= 
0.25 ml/sample. The radioactivity per fraction could then be 
correlated with the optical density readings from the recorder. 
Figure 3.3. shows a typical optical density pattern of rRNA 
fractionated by this method. S values were calculated from the 
standard ribosomal RNA 18S and 30S peaks by the equation 
= (209) 
where dx = distance travelled by the reference RNA from the 
top of the gradient in ml. 
dy = distance travelled by the unknown species in ml. 
Sx = s value of the reference RNA 
Sy = s value of the unknown species. 
Specific activities of the collected samples were expressed 
in ter~s--of dpm/OD on the basis of OD being a measure of RNA 
concentration per fraction. 
3. 3. HISTONE PURIFICATION 
3. 3. 1. ISOLATION OF NUCLEI (210) 
~ 33% rat liver homogenate was prepared in a Potter Elvehjem 
homogenizer with teflon pestle in 0.33 M Sucrose - 0.004 M CaC12 (4°c) and centrifuged at 600 x g for 15 minutes. The sediment 
containing the nuclei was homogenized in three times its volume 
0.25 M Sucrose-0.003 M cac12 and layered over an equal volume 
o f 0.34 M Suc:rose-0.003 M cac12 then spun at 1,500 x g for 
15 minutes. 
22. 
The supernatant was discarded and the pellet homogenized in nine 
times its volume 2.4 M Sucrose-0.003 M CaC12 ; the pelleted nuclei 
resulting from 70 minutes centrifugation at 45,000 x g were washed 
in a medium containing 0.25 M Sucrose, 0.025 M KCl, 0.01 M MgC12 , 
0.05 M Tris, adjusted to pH 7.6 with 1 N HCl. This yielded 
a white pellet of nuclei which, on microscopic examination, were 
found to be contaminated only slightly with erythrocytes. 
3. 3. 2. EXTRACTION OF HISTONE 
The histones isolated either directly from purified nuclei or from 
crude nucleoproteins prepared by citrate buffer treatment 
(0.14 M NaCl, 0.01 M Tri-sodium citrate pH= 7.5) of the nuclei 
(211) were found to be identical on polyacrylamide gel 
electrophoresis. Histones were therefore routinely extracted 
from the nuclei without prior isolation of chromatin. Nuclei 
were homogenized in 6 ml 0.25 N hydrochloric acid (4°c) and 
extracted for 1 hour at 4°c. Debris was spun off at 12,000 x g 
(10,000 rpm) for 15 minutes and the supernatant used for 
further purification. 
The HCl-extract was brought to 14% trichloroacetic acid (TCA) 
with 1 ml 100% TCA (w/v) and allowed to stand for 15 minutes. 
The precipitate collected by 3 minutes centrifugation in a desk 
centrifuge ~as suspended with stirring in 6.0 ml 0.25 N 
hydrochloric acid (4°C). After 30 minutes insoluble material 
was spun off, and the supernatant brought to 25% TCA and again 
allowed to stand for 15 minutes. The precipitate collected as 
above was redissolved in 2.0 ml 0.25 N hydrochloric acid and, 
as before, insoluble material centrifuged off. The resulting 
--supernatant contained the purified histones (see 3.3.3). 
3. 3. 3. PURITY OF THE HISTONE SOLUTION 
The purity of the histone preparation was judged on the basis 
of polyacrylamide gel electrophoresis according to the method 
of Panyim & Chalkley (212) on 15% gels containing 2.5 M urea. 
Pre-electrophoresis was run for 2 hours at 2mA/gel for gels 
in 10 cm long glass tubes using 0.9 N acetic acid solution 
as electrolyte. 
23. 
After application of samples, which were dissolved either in 
6 M urea containing 0.15 mercaptoethanol or brought to 15% 
sucrose, eJ ~ctrophoresis was continued for 2 - 3 hours at 
2mA/gel. Gels were stained with 0.1% (w/v) Amido Black in 
25% (v/v) ethanol, 7% (v/v) acetic acid and destained in a solution 
of 25% ethanol, 7% acetic acid. The patterns of samples under 
investigation were compared with those of calf thymus histone 
prepared according to the method of Busch et. al. (211); these 
yield the 5 characteristic bands as seen in Figure 3.4. (a). 
Samples for electrophoresis were taken from each purification 
step, and, where radioactive histones were tested, protein 
content (216) and radioactivities were also determined, 
(Figure 3.5 Schematic representation). 
Electrophoresis of the HCl-extract showed the 5 characteristic. 
histone bands and in addition a large number of contaminant 
bands (see figure 3.4. (b) ). Most of these contaminants·, which 
were not identified, precipitated with the histone at TCA 
concentrations from 0.5 - 25% (v/v), but their trichloroacetates 
were subsequently less soluble in 0.25 N hydrochloric acid in 
which the histone dissolved. This property of the contaminants 
was used to purify the histones. 
The first 14% TCA precipitate had an electrophoretic pattern 
similar to that of the original HCl-extract, but the contaminant 
bands were fainter. The precipitate, taken up in a 0.25 N HCl 
volume equal to that of the original extract contained considerable 
amounts-'of material which would not dissolve in this acid. The 
insoluble material was centrifuged off, resuspended in 0.25 N HCl, 
and the soluble part subjected to electrophoresis revealing histones 
heavily contaminated with slow-moving fractions. 
The supernatant containing the HCl soluble material of the first 
TCA precipitate was brought to 25% TCA, and allowed to stand for 
15 minutes. The resulting precipitate was collected by 
centrifugation in a desk centrifuge at a maximum speed 
(approximately 3,000 rpm) for 2 minutes. 
24. 
Figure 3. 4. POLYACRYLAMIDE GEL ELECTROPHORESIS OF HISTONE 
... 
(a) (b) ( C) 
a) Histone isolated by the method of Busch et. al. (211) 
b) HCl extract showing contaminant bands. 
c) Histone isolated as described in methods (3.3.2). 
Electrophoresis 
Staining 
2 hours at 2mA/gel, 0.9 N acetic acid electrolyte. 
30 minutes in 0.1% (w/v) Amido Black in 25% 
ethanol, 7% acetic acid. 
25. 
Figure 3.5. PURIFICATION OF CRUDE HISTONE EXTRACT 
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Distribution of radioactivity during purification of histones 
isolated from a control rat after triple labelling (i.e. 50 µCi 
3H-methionine, 80 µCi 14 C-acetate, and 400 µCi 32 P/20o-2so ' g 
body weight). 
The underlined steps represent the final purification procedure. 
26. 
The TCA precipitate was taken up in 0.25 N HCl (one third of the 
original HCl extract volume) and insoluble material was spun off. 
This HCl supernatant on electrophoresis showed qualitatively 
an identical composition to that of calf thymus histone, and even 
at very high sample concentrations showed no protein contaminant 
(Figure 3. 4. (c) ) • 
The HCl insoluble material of the last TCA precipitate, however, 
resuspended in 0.25 N HCl and subjected to electrophoresis 
contained, in addition to histone, the contaminants seen in the 
original HCl extract. 
·. With electrophoresis as a criterion it could be seen that the 
repeated TCA precipitation effectively removed protein contaminants. 
The decrease in specific activities of the final histone 
solutions as compared with those of the crude histone extracts 
indicates that some of the contaminants were labelled (Figure 3.5). 
The reprecipitation, however, also led to losses of histone, 
possibly altering the five main fractions to differing degrees since 
the various histones are known to have different solubilities 
in TCA ( 2 9 7 ) . 
3. 3. 4. RADIOCHEMICAL PURITY OF METHYLATED HISTONE 
The methylation of tRNA (267) has been shown to increase at 
times of increased genetic activity (268,269). Low molecular 
weight RNA has been detected in close association with chromatin -
Bonner et. al. (142,143) have imparted a specific repressive role 
on this'chromosomal RNA'; other workers (144-146) regard it as 
contaminat;Lng tRNA. 
To ascertain whether the content of radioactive methyl groups 
in the histone preparation was due to a contamination by RNA or 
represented a genuine histone methylation, our methylated histone 
samples were tested for the possible presence of contaminating RNA. 
a) RNase treatment : 
Samples were subjected to RNase and the rate of reaction followed 
spectrophotometrically (285). Whereas control experiments with 
added RNA as substrate gave the expected results, no change of OD 
was observed when histone served as substrate. This indicates that, 
within the sensitivity range of the Kunitz method, the histone 
preparations were free of digestible RNA. 
2 7. 
Table 3. 1. 
RECOVERY OF PROTEIN AND RADIOACTIVITY AFTER RNase AND TRYPSIN TREATMENT OF METHYLATED HISTONE 
Sample % Recovery (of total added) 
TCA Supernatant Precipitate 
Protein 3 H dpm Protein 3 H dpm 
Zero time 25 42 75 58 ] Incubated 1. 30 43 70 67 2. 27 34 73 66 
Zero time 25 43 75 57 
J 
Incubated 1. 75 69 25 31 
2. 65 74 35 26 
RNase 
Trypsin 
28. 
Further samples were passed over a Sephadex G50 colunm 
(using 0.01 N HCl - 0.9% NaCl (w/v) as eluent). before and after 
RNase treatment. Should contaminating RNA have been present, 
labelled low molecular weight nucleotides would be separated from 
the higher molecular weight histone. 18 - 36 Hours incubation 
of the histone at room temperature (284) however, resulted in 
neither a shift of the protein peak towards the inner volume, 
nor the appearance of any radioactivity within the inner volume 
(Figure 3.6). 
1 mg methylated histone in 0.25 N ~Cl buffered to pH= 5 
with 1 N NaOH was incubated with 6.65 µg RNase (Sigma Grade 1 
bovine pancreas RNase EC 2.7.7.16) in 0.1 M potassium acetate 
buffered to pH= 5 with 100% acetic acid (284) for 20 minutes 
at 37°c. The reaction was terminated by addition of TCA 
(6.5% final concentration) and the mixture al~owed to stand at 
4°c for 15 minutes. The precipitate was centrifuged off at 
8,000 x g for 15 minutes. The TCA supernatant was decanted off 
and the precipitate taken up in 1 ml pH= 7.6 buffer (see Trypsin 
digestion). The radioactivity and protein content (216) of 
each were then determined. 
As histones are partially soluble in TCA (see above 3.3.3) the 
TCA precipitation of protein was incomplete (Table 3.1). 
Nevertheless, it is evident that RNase treatment of histone did 
not alter the percentage recovery of Lowry positive material 
(216) in the TCA supernatant nor lead to an increase of radioactivity 
in this supernatant (Table 3.1). 
----
b) Trypsin digestion : 
1 mg methylated histone in 0.25 N HCl buffered to pH= 7.6 with 
1 N NaOH was incubated with 5 µg trypsin (Seravac Grade 1 bovine 
pancreas trypsin EC 3.4.4.4.) in 0.2 M borate - 0.005 M cac1 2 
adjusted to pH= 7.6 with 1 N HCl (286) for 20 minutes at 37°c. 
TCA precipitation was carried out as described above (RNase treatment). 
The pronounced increase of radioactivity and Lowry positive material 
in the TCA supernatant indicated the presence of labelled peptide 
(Table 3.1}. 
Figure 3.6. 
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COLUMN CHROMATOGRAPHY OF RNA AND HISTONE 
BEFORE AND AFTER RNase TREATMENT 
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Figure 3.7. :!UGH VOLTAGE ELECTROPHORESIS OF TRYPSIN DIGESTS 
OF METHYLATED HISTONE 
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TCA supernatant of trypsin digest (seep. 28) desalted by 
passing it over a Dowex 50 (X4) H+ column, and drying of 
the NH 40H eluent under nitrogen. 
Total radioactivity= 277.0 3H dpm 
High Voltage Electrophoresis 60 minutes, 3000 V 
Pyridine-acetate buffer pH= 3.6 (299) 
31. 
Trypsin digests were subjected to high voltage paper electrophoresis 
using pyridine-acetate buffer pH= 3.6 (299) as mobile phase. 
The TCA supernatant of the digest described above was desalted by 
passing it over a Dowex 50 (X4) H+ column; the water eluent, 
devoid of radioactivity, was discarded and the 1 N NH 40H eluent dried under nitrogen. The resulting material (277.0 3 H dpm) 
was applied and electrophoresis continued for 60 minutes at 
3000 V. Dried electrophoretograms were stained with ninhydrin (300 mg ninhydrin,3 ml glacial acetic acid, 100 ml ethanol) and 
stained portions cut out for determination of radioactivity. 
Under the conditions chosen histones remained at the origin, and 
RNA or oligonucleotides because of their charge at this pH would 
also remain stationary or move toward the cathode. The ninhydrin 
positive regions returned 80% of the radioactivity applied. 
(Figure 3. 7). 
c) Acid hydrolysis : 
Labelled histone samples were hydrolyzed in 6 N distilled HCl for 
24 hours at 110°c, and the hydrolysates applied to a Dowex 50 (X4) H+ 
column. Any contaminating RNA or nucleotide wpuld appear in the 
water eluent - this contained no radioactivity. The 1 N NH 40H eluent in which degraded peptides and amino acids would be found, 
contained 100% of the radioactivity applied to the column. 
The methylated histone samples were therefore not contaminated 
with RNA and the content of radioactive methyl groups indeed 
represented a true histone methylation. 
3. 4. SCHEDULE OF TREATMENT OF EXPERIMENTAL ANIMALS 
----Hepatic tyrosine transaminase activity is known to vary during 
each 24 hour period in untreated rats given free access to dietry 
protein and exposed -to alternate periods of light and darkness (213,214,215). In addition, increases of protein in the diet of 
experimental animals give rise to increases in the activities of liver 
enzymes (3). Standard starvation periods of 20 hours were therefore 
observed: In all cases the male albino rats (200-250 g body weight) 
were fasted from 1.00 p.m. of the preceding day until 9.00 a.m. of the day of the experiment. Hormone (either hydrocortisone 10 mg/200-250 g 
rat) or insulin (0.05 mg in 0.1 N hydrochloric acid/200-250 g rat) 
was administered by intraperitonaeal injection, and induction periods 
were taken from this time. Starvation continued until the time of 
killing. The animals were stunned by a blow on the head, decapitated, 
and exsanguinated before removal of the livers. 
32. 
TAT enzyme extracts were prepared and assayed immediately 
(see 3.1.2.ii). 
RNA synthesis was investigated by measuring the incorporation of 
radioactive precursor: 250 µCi Adenine-2- 3 H was administered 
by intraperitonaeal injection to each 200-250 g animal exactly 
1 hour before sacrifice. 
Methylation, acetylation and phosphorylation of total histone 
were measured by the incorporation of ( 3 H-methyl) methionine, 
sodium acetate-1~ 14 C, and 32 P respectively. Induction periods 
from 15 minutes to 6 hours were investigated and in all cases 
radioactivity was injected intraperitonaeally 15 minutes before 
sacrifice. 
Standard doses were : 
i) Methionine-( 3 H-methyl), aqueous solution 1 mCi/ml 
100 mCi/mmole 
ii) 
· 50 µCi/200-250 g body weight 
Na-acetate-l- 14 C, aqueous solution 1 mCi/5 ml 
59 mCi/mmole 
80 µCi/200-250 g body weight 
(Methionine and acetate were combined for injection in a 
cocktail containing 2.0 ml 14 C-acetate + 0.25 ml 3H-methionine 
for 4 animals. 0.45 ml was injected 
= 50 µCi 3 H-methionine + 80 µCi 14C-acetate). 
iii) 3 2 P Phosphoric acid 
400 µCi/200-250 g animal. 
__, 
In cases of triple isotope labelling, 32 P was injected 
separately, in volumes varying according to the age of the 
32 P solution. 
Control animals, injected only with radioactivity, were investigated 
with the hormone-treated animals at each time. 
33. 
3. 5. RADIOACTIVITY DETERMINATIONS 
All samples were counted in 10 ml of toluene scintillation 
cocktail comprising 0.8% TLA (Beckman fluoralloy formula TLA) 
and concentrations of BBS-3 (Beckman Biosolv solubilizer 
formula BBS-3) dep~nding on the type and size of the sample 
to be counted. 
0.4 ml 1. N NH 40H eluent (TAT assay) : 10% BBS-3 (see 3.1.2). 
0.25 ml sucrose solution (gradient centrifugation) 6% BBS-3 
3% H2o (see 3.2.2). 
0.1 ml 0.25 N HCl solution of histones : 2.5% BBS-3 (see 3.3.2). 
The radioactivity of the samples was determined using appropriate 
discriminator settings with a Beckman Model LS 250 Liquid 
Scintillation Counter to 3% error. Cpm, corrected for 
background, were converted to dpm by use of quench curves built 
up for this system and a computer programme correcting for 32 P 
"spillover" into 14 c and 3 H channels, for 14 C "spillover" 
into the 3 H channel, and for decay of 32 P (298). 
To compensate for variations in the specific activity of the 
precursor pools in the different animals as a result of weight 
variations (from 200-250 g) yet a constant dose of radioactivity, 
all radioactivity data were corrected to an average liver weight of 
6 g. A direct proportionality between liver weight and body 
weight does probably not occur. However, any attempt to achieve 
equal labelling of the precursor pool by adjusting the dosage of 
the al~dy small volume (0.45 ml) of highly radioactive solutions, 
would have introduced even greater errors in dosing. 
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4. RESULTS 
I n ·all sets of experiments the various parameters during . an 
i nduction per+ od fr·om O to 6 hours were investigated. Enzyme 
activity, RNA synthesis and histone modification were studied 
separately in different groups of animals. As anim, s from 
the same stock were · used, and were subjected to identical 
treatment prior to and during the induction periods, it was 
presumed that the events described at each specific time could 
va lidly be compared. Only in a few pilot runs were all three 
parameters measured in a single animal. The results of these 
experiments corresponded with those done separately in 
different animals. 
4. 1. TYROSINE TRANSAMINASE 
Control animals, not receiving hormone treatment, were 
investigated at each time interval to account for any indogenous 
changes of hormonal activity which may have occurred in the 
course of the experiment as a result of prolonged starvation. 
The levels of TAT activity in these rats varied little within 
the experimental period apart from a very slight drop at 
6 hours. This might be related to the normal diurnal 
variation in TAT activity (214) (see Figure 4.la). 
Hydrocortisone administration had no measurable effect on the 
enzyme until 4 hours after injection had elapsed, whereupon 
t he activity rose to twice that of controls. (Figure 4.lb. 
and Table 4.1.). A further increase to 4 times the control level was 
noted after 6 hours. 
Hydrocortisone induction of TAT activity is well documented 
(4,182,184). The effect of insulin on TAT has not been 
comprehensively reported. Kenney et. al. (181,217) have 
compared hydrocortisone, glucagon and insulin induction both 
in vitro and in vivo. They noted that insulin injection 
rapidly in9reased the enzyme activity, which then declined to 
control levels despite the continuous presence of hormone. 
However, with hydrocortisone the high level was maintained 
throughout the experimental period. The authors inferred 
different mechanisms by which the two hormones operate. 
I 
TABLE 4.1. 
Induction 
Period 
30 minutes 
60 minutes 
2 hours 
3 hours 
4 hours 
6 hours 
Each value 
4 animals. 
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HYDROCORTISONE AND INSULIN INDUCTION OF TAT ACTIVITY 
TAT Activity (µmoles transaminated / mg protein 
per 10 minutes+ standard deviation). 
Control Hydrocortisone Insulin 
0.02993 + O.OJ:26 0.01852 + 0.00573 0.01852 + 0.00567 
- -
0.01662 + 0.00520 0.01910 + 0.00743 
-
0.02431 + 0.0134 0.03504 + 0.01458 0.02412 + 0.00756 
-
0.03379 + 0.007198 
0.03254 + 0.00898 0.06635 + 0.02254 0.02773 + 0.00664 
0.01592 + 0.00340* 0.06190 + 0.01626 0.08410 + 0.004339 
Average of all 
controls 
0.025095 + 0.01113 
is the average ( + standard deviation) of a minimum of 
* Significance of difference between the 6 hour value and the average 
of all controls P = 0.1. 
Induction 
Period 
30 minutes 
60 minutes 
2 hours 
3 hours 
4 hours 
6 hours 
Induction Factor 
TAT activity of experimental rats 
TAT activity of control rats 
Hydrocortisone Insulin 
0.618 0.618 
0.6 0.8 
1. 2 1.0 
1. 2 
2.04 0.92 
3.89 5.28 
Significance (P) 
of the difference 
between injected 
and control rats 
(i.e. average of 
all controls). 
Hydrocortisone Insulin 
0.3 0.3 
0.1 0.2 
0.1 0.9 
0.2 
0.001 0.7 
0.001 0.001 
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Figure 4 .1. HORMONE INDUCTION OF TYROSINE TRANSAMINASE ACTIVITY 
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Our experiments showed that the induction effect of insulin on 
TAT occurs somewhat later than that of hydrocortisone under 
similar conditions. Whereas the latter had already caused a 
two-fold increase after 4 hours, insulin induction was not 
manifest until after 6 hours (see Figure 4.lc, and Table 4.1). 
At this stage there wa~ a five-fold increase in TAT activity. 
4.2. RNA SYNTHESIS r 
One of the early responses in target cells to hormone treatment 
is the de novo synthesis of RNA in the nucleus (32). This 
involves the pre-ribosomal and ribosomal RNA types (162,163) 
and the DNA-like RNA species (173,218). The well charac-
terised 45S ribosomal RNA precursors are transformed by a 
complex series of reactions to the mature 18S and 30S RNA's (164,174,175). Weinburg et. al. (175) have proposed a 
mechanism by which 45S pre-rRNA is converted into a 41S 
molecule, which is further split into immediate precursor 
molecules, a 32S RNA for the 28S and a 20S RNA for the 18S. 
Approximately 50% of the 45S RNA molecule is thus discarded 
during the maturation process (164,174). The high molecular 
weight DNA-like RNA is composed of 2 types, a non-informational 
species which is restricted to the nucleus (219), and an 
informational species which is also found in the cytoplasm (174,219). Although the mechanism of cleavage is not yet 
certain, a pathway has been proposed (174) following the sequence 
sos~->30S~->l8S~->10S. These DNA-like species have the 
characteristics associated with mRNA, (173,218,220), and their 
synthesis is stimulated by hormone to the same extent as that 
---
of rRNA .. (162,163). 
Low molecular weight RNA's are also increased in response to 
hormone treatment (173). These include transfer RNA (162,173) 
and DNA-like molecules (221) which Kenney et. al. (173) have 
labelled 'high molecular weight DNA-like degradation _products'. 
This designation would agree with the cleavage pattern of 
Sekeris et. al. (174) (50S--->30S--->18S--->l0S). 
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Figure 4.2.1. 3 H-ADENINE INCORPORATION INTO RNA OF CONTROL ANIMALS 
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Figure 4.2.2. EFFECT OF HYDROCORTISONE ON ~H-ADENINE 
INCORPORATION INTO RNA FRACTIONS 
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In the present experiments, _hydrocortisone was administered, 
3 H-Adenine was injected, rRNA and 'rapidly labelled RNA' were 
iso l ated and fractionated as described in Methods (3.2). RNA 
synthesis was measured by incorporation of the labelled precursor 
in experimental animals 2, 4 and 6 hours after hormone injection, 
and in uninjected _animals at 2, 4 and 6 hours. 
In control rats radioactivity appeared in low molecular weight 
fractions (3 - SS), the two rRNA regions {18S and 30S) and also 
in a high molecular weight fraction (40S) (Figure 4.2.la-c). 
Specific activity determinations (dpm/OD. See Figure 4.2.ld-f) 
of the RNA isolated from control animals show that there was no 
significant change in incorporation into low molecular weight 
species throughout the experimental period. With the 16 - 30S 
and 40S areas regular incorporation was maintained from 2 to 
4 hours, whereas at 6 hours there was a slight increase which 
may reflect the changeover in the rat's metabolism to 
starvation conditions (140). 
The hormonal effect on RNA synthesis in animals injected with 
hydrocortisone was evident two hours after administration, when 
the specific activity of total RNA was twice that of controls; 
this level w.as maintained at 4 hours, after which there was a 
rise to 3 times control values at 6 hours (Figure 4.2.2a). 
No gross changes in the proportion of the amounts of the various 
.RNA fractions were detected as the optical density profiles 
were not affected. The incorporation of radioactivity, however, 
was found to increase in all fractions (Figure 4.2.3a-d). 
Two slightly different patterns were observed at 4 hours : 
one in which the distribution of radioactivity was more or less 
similar to that at the 2 and 6 hour periods (Figure 4.2.3b); 
the other where there was an increase in the 8 - lOS region 
and more diffuse incorporation between 16 and 32S {Figure 4.2.3c). 
By specific activity determinations, low molecular weight RNA 
(3 - SS) was shown to increase only slightly above control levels 
at 2 and 4 hours, followed by a high incorporation at 6 hours, 
viz. 3 times the 6 hour control values (Figure 4.2.4). 
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Figure 4. 2. 3. 3 H-ADENINE INCORPORATION INTO RNA OF HYDROCORTISONE 
INJECTED ANIMALS 
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Figure 4.2.4. 3 H-ADENINE INCORPORATION INTO RNA OF HYDROCORTISONE 
INJECTED ANIMALS 
Sucrose gradient fractionation 
a) 2 Hours 
\ 8~10S 
~. /\ ~ ... 
\ 
. \ 40S '-. 24-26S • 
. • I 
•. I\ • 
·.. • I 
· ...... 1 •, ;• .·· 
......... • ···.• .... ··· 
10 
b) 4 Hours 
3-SS 
• 
\ ... \s-1os 
l \ \ 40,S 
\\24-26S / 
· .. ·, .-•, / .·· 
' , ... . . 
·-.~.·· ··.~ .... , ... · 
..... 
10 
Fraction No. 
Direction of Gradient 
Specific Activities 
c) 6 Hours 
4 • 3-SS 
\irlOS 
3 • \ 
2 
24-26S 
• 
. . 
• ,. I == . . 
/ ·. 
1 
I . ;: 
j /! 
· .. 
-----> 
. . : 
···" . 
· .. 
10 
40S 
Control animals, average of 4 experiments. 
Hydrocortisone injected animals, average of 6 experiments. 
43. 
The 8 - lOS RNA was already raised at 2 hours to double the 
2 hour controls. At 4 hours these species were increased two-
to three times the corresponding controls (Figure 4.2.4) while 
at 6 hours the increase had become four-fold. 
In the 18 - 30S region, where a maximum peak was seen between 
24 and 26S, a similar induction pattern was found (viz. twice 
control values at 2 and 4 hours, three times control values at 
6 hours). 
In the heavy RNA region, -40S, the two-fold rise at 2 hours 
increased slightly at 4 hours and fell again at 6 hours to the 
two hour level. 
The RNA fractions isolated under the present experimental 
conditions were not characterised with regard to base 
composition. It was therefore not possible to differentiate 
with certainty between DNA-like RNA and other species. 
Hydrocortison~ effected a pronounced increase in synthesis 
of all types of RNA. In the 40S region containing both heavy 
DNA-like RNA and 45S precursor ribosomal RNA, the maximum 
incorporation was found 4 hours after hormone administration 
(Figure 4.2.2e). 
Ribosomal RNA, 18S and 30S (and possibly their immediate 
20S and 32S precursors (175) would comprise the 18 - 30S 
region which was increased to a maximum at 6 hours (Figure 4.2.2d). 
This was--also the case for the 8 - lOS region which would contain 
the low molecular weight DNA-like molecules (164,173,221) 
(Figure 4.2.2c). 
In the light RNA region (3 - 5S) where sRNA would be the major 
component, the early response to hydrocortisone was not as 
great as that of the larger RNA species. However, after 6 hours 
the increase was equal to that of the other regions (Figure 4.2.2b). 
44. 
The chromosomal RNA of Bonner et. al. (142) would not be detected 
by the methods used in these experiments. 
Template activity of rat liver chromatin and RNA polymerase 
activity are increased by administration of insulin (186) to 
an extent similar to that caused by hydrocortisone (7,14). 
Since increased RNA synthesis is the result of both of these 
changes, our investigations included only one cross experiment 
with insulin. Two hours after administration of this hormone, 
the increased amount of 3 H-Adenine incorporated was identical 
to that in response to hydrocortisone (Figure 4.2.4a). 
4. 3. HISTONE MODIFICATION 
The possible role of histones as genetic repressors and 
their relationships with non-histone chromosomal proteins, DNA 
and RNA polymerases has already been discussed (see Section 1). 
The effects of hormone or other inducing agents on the structural 
modifications of histones remain uncertain (46). Conflicting 
results have been reported with regard to acetylation reactions 
in response to hydrocortisone (188,222), and phytohemaglutinin 
(37,223). Pogo et. al. (188) have found an increase in RNA 
synthesis concomitant with increased acetylation of arginine-
rich histones in hepatic tissue of cortisol-treated rats, while 
Gallwitz & Sekeris (222) found no such accompanying modification 
of histone. Both negative (36) and positive (224) responses 
to hydrocortisone have been reported involving the phosphorylation 
----
of the ··lysine-rich histones. 
The mechanism of induction by hormones has been related to . 
(i) stimulation of the activity of the enzymes responsible for 
histone modification (36,79) 
(ii) direct interaction of hormone with histone (150,152,156) 
(iii) interaction of hormone with the metabolism of non-histone 
chromosomal proteins and their inter-relationships with histone 
and RNA polymerase (112,132,134-139) (See Section 1). 
45. 
On a structural basis, acetylation and phosphorylation of the 
basic proteins associated with chromatin would result in a 
weakening of the electrostatic bonds between histone and DNA 
(47,53,60) rendering the DNA more available for transcription 
(61,65) or replication (46,65). Acetylation and phosphorylation 
of arginine-rich histones have been related to RNA synthesis 
(transcription) (65,187,190,223) while the phosphorylation of 
lysine-rich histone fl appears to accompany DNA synthesis 
(replication) (82,225-231). 
Methylation of histone would result in an increase of the 
positive charge, hence a tightening-up of the bonds between 
histone and DNA (46,63). Paik and Kirn (295) have shown that, 
in contrast to mono- and trirnethylation, di~ethylation of the 
E-arnino groups of lysyl residues, results in a decreased 
basicity at the substituted group. Thus dirnethylation of 
such residues could conceivably have a similar effect on the · 
histone-DNA interaction to that of acetylation and phosphorylation. 
The function of rnethylation remains a mystery (66,191,232) -
it may be related to a decreased availability of the genome 
for transcription after the latter has been completed (63,191) 
or increased structural stability of the nucleoprotein against 
damage or degradation (97,188-190,233). 
4. 3. 1. ACETYLATION 
It is generally accepted that the acetylation of a-amino 
groups of the NH 2-terrninal residues o
f histone (234) occurs in 
the cyt6plasrn (34) relatively late in the cell cycle (235) 
and is related to the initiation of histone biosynthesis 
(34,235). These acetyl groups, found in histones fl (70,236) 
and f2a (67,~34,237,238), do not show an appreqiable turnover 
throughout the cell cycle (100). 
In contrast, the acetylated E-arnino groups of internal lysyl 
residues (67,70,97,238-240) turn over at an appreciable rate 
(70,101,239). This acetylation reaction occurs in the nucleus 
(70,239,241) after histone synthesis has been completed 
(72,74,97) preferentially on the arginine-rich histones 
(41,70,71,74,189). 
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EFFECT OF HYDROCORTISONE AND INSULIN ON 
HISTONE ACETYLATION 
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Figure 4. 3. 2 • EFFECT OF HYDROCORTISONE AND INSULIN ON 
ACETYLATION OF HCl EXTRACT PROTEINS 
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Nuclear, histone specific (68) transacetylases (41,68,72-75) 
which show certain organ specificity (73) have been isolated, 
as have deacetylases (98). Hormone effects on these enzymes 
have not been reported; the transacetylases, however, are 
insensitive to cyclic AMP (73,79). Many studies (see above 
section 4.3 and 79,97) have related this nuclear acetylation 
reaction with RNA synthesis, the former preceding the latter 
(188,189,237,241,242). 
In our experiments, when acetylation was investigated by the 
incorporation of 14 C-acetic acid into total histone (see 3.4.) 
in the absence of intensive cell division, during the relatively 
early stages of induction by hormones (see 4.1., 4.2), the 
nuclear acetylation of the internal lysyl residues of histones 
has been measured. 
A very slight rise in 14 C incorporation seemed to occur 30 minutes 
after hydrocortisone administration, followed by a return to 
control levels during the remainder of the experimental period 
(Figure 4.3.1~ and Table 4.2). However, under the conditions 
of these experiments, very small increases in acetylation induced 
by the hormone may well fall within the biological variation of 
the control animals, and the significance of the rise after 
30 minutes remains questionable. 
30 minutes after insulin injection, there was a 20% increase 
in radioactivity above control levels - this was maintained 
until the 6 hour period when there was a further increase to 
50% above the corresponding control values. 
----
The similarity of incorporation patterns of the HCl extracts 
and the histone solutions indicate that acid-soluble 
non-histone contaminants did not contribute to the increases in 
radioactivity seen under the influence of insulin (Figures 4.3 .1 
and 4.3.2) . RNA acetylation does not occur under the conditions 
of histone acetylation (243) and non-histone chromosomal proteins 
are not readily acetylated (46). 
49. 
4. 3. 2. PHOSPHORYLATION 
Since all constituents of chromatin incorporate 32 P (46,81) 
the results of experiments involving phosphorylation of any · 
single component must be regarded as tentative unless stringent 
purification measur~s have been applied. Some chromosomal non-
histone species remain associated with histones even through 
exceedingly elaborate separation procedures (81). 
Non-histone chromosomal proteins (NHC proteins) are known 
to be present in high concentrations in the chromatin of meta-
bolically active tissues (110,116,126-131) preferentially in 
regions of the chromosome most active in RNA synthesis (11). 
They are subject to structural modifications by means of enzymatic 
phosphorylatiop reactions (111,124,244-247) particularly at the 
time of gene activation (246,247), and under the influence of 
hormones (132,134). Moreover, their specific activities with 
regard to phosphate content, are higher than those of 
~ phosphorylated histones (124,140,288) and their phosphorylation 
is facilitated by their interaction with these basic proteins 
(113,114,116,288). 
Although most of these acidic proteins (114,116) should have 
been removed from the histone preparation by HCl and TCA treat-
ment (see 3.3.2), their presence as phosphorylated contaminants 
cannot be ignored. It is interesting to note, however, that 
Sonnenblicher et. al. (248) have found acid treatment of 
chromatin capable of giving histones the apparent characteristics 
-----of acid~c chromosomal proteins. 
The phosphorylation of histones themselves has been extensively 
studied. All types are phosphorylated at least in some 
organisms (46,81-84) although the extent of modification of 
individual histone fractions varies according to biological 
source (249) preparation procedures · (250,84) and method of 
phosphate incorporation (124). 
50. 
Histone kinases and phosphatases must be present in tissues 
because of the observed uptake and turnover of histone-bound 
phosphate in vivo (46,61,78,86,224,247). Several protein 
kinases both cyclic AMP-dependent (77,79,80,251-254,276,288) 
and independent (8q,227,276) have been found to phosphorylate 
histone (although not specifically (80) ) , fl being the 
best substrate (76-78). A histone and protamine specific 
phosphatase has been isolated by Meisler & Langan (99). 
Both hydrocortisone (244) and insulin (36) have been reported 
to induce the phosphorylation of histone. The role of cyclic 
AMP in these· reactions remains a subject under dispute 
(36,38,39,76,79,224,251,254,276). Correlations have been made 
between this modification of histones (except fl) and RNA 
synthesis (36-38,61,225,226,247,249,255); between the 
phosphorylation of fl and RNA synthesis (65,76,190) and DNA 
synthesis (82,225-231). A model accounting for the effect of 
phosphorylation on histone - DNA interaction involving a local 
turning away of the protein from the DNA wide groove has been 
proposed by Lewin (62), the result being an increased 
availability of the DNA for such processes as transcription 
and replication. 
In our experiments phosphorylation of total histone was 
investigated by the in vivo incorporation of 32 P (see 3. 4. } . 
The results indicate, if anything, a slight repression o f 
incorporation after hydrocortisone administration in comparison 
with cont.J?ol animals until 2 hours after hormone injection 
(Figure 4.3.3b, and Table 4.2.). This effect of hydrocortisone 
is in agreement with the results of Langan (36) but not with 
those of Murt~y et. · a1. (224), who reported an increase in histone 
phosphorylation in response to hydrocortisone. The incorporation 
into the crude HCl extract, however, indicated that non-histone 
components became heavily labelled after 4 hours (Figure 4.3.4a). 
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Figure 4. 3. 3. EFFECT OF HYDROCORTISONE ANP INSULIN ON 
HISTONE PHOSPHORYLATION 
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Figure 4 . 3 . 4 . EFFECT OF HYDROCORTISONE AND INS6LIN ON 
PHOSPHORYLATION OF HCl EXTRACT PROTEINS 
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Insulin administration caused a 50% increase in 32 P incorporation 
above controls within 60 minutes (see Figure 4.3.3c); the level, 
however, dropped to equal that of controls between 2 and 6 hours. 
The incorporation pattern in the HCl extract closely followed 
the activity in the histone fraction (Figure 4 . . 3.4). 
Contamination of the histone preparation by RNA would seem 
unlikely because of parallel experiments where RNA and histone 
were investigated from the same animal, 32 P incorporation into 
RNA was very low in comparison with that into histone. The 
specific activities of RNA would need to be extremely high to 
account for the observed histone radioactivity both in control 
and injected animals. Further, for example, at the 2 hour 
period where RNA incorporation of labelled adenine had increased 
significantly above control levels under the influence of both 
hydrocortisone and insulin (see 4.2), neither hormone effected 
any 32 P incorporation into histone at this time. 
Though the possibility of NHC protein contamination in our histone 
preparations cannot be excluded, the results indicate that the 
hormonal influence on phosphorylation preceded that on RNA 
synthesis (see 4.2). 
54. 
4. 3. 3. METHYLATION 
Me thylation occurs after the formation of the peptide bonds 
(95,97) in all histone fractions (88) except the very lysine-rich 
fl (63,191,259). The biological significance of the histone 
methylation reaction remains to be elucidated (66,191,232,257). 
No time correlation has been found between histone methylation 
and the synthesis of RNA, DNA, histone or NHC protein (98). 
In experiments with phytohemaglutinin-treated lymphocytes (97), 
synchronized cell cultures (63,95) and in regenerating liver (191), 
lysine residues have been identified as the carriers of methyl 
groups (63,89,90) chiefly in the arginine-rich histones 
(63,191.,258) after DNA synthesis and histone synthesis have 
begun to decline (191). Since this modification of the basic 
proteins would augment their net charge (mono- and trimethylation, 
see page 59) and hence increase their affinity for DNA , various 
-
authors have implicated the reaction with the compression of the 
chromatin prior to mitosis (63,191). The specificity of the 
methylating enzymes (41,92-94,260,261) for certain residues 
(92,93) of particular histone fractions (92), and their apparent 
tissue specificity (88), suggest that this alteration is inherent 
in the function of histones. 
Nuclear methylase enzymes ('Methylase III' (260) ) have been 
isolated from various sources (94,96,97,259,260). These enzymes 
transfer the methyl group of S-adenosyl methionine (95-97) to 
the £-amino groups of lysine (63,88,258) preferentially in 
arginine-rich histones (258,260) yielding mono- (63,89), 
di- (63) and tri- (90) methyl derivatives. Not all lysine 
residues are, however, thus affected - approximately one in eleven 
lysine residues of calf thymus histone f2al, and 1 in 12 - 13 
residues of f3 are methylated (67,238). A pertinent 
observation of Bonner et. al. (238) was that £-N-acetyl lysine 
and £-N-methyl lysine appear in a cluster of five basic amino 
acids in the primary DNA binding site of fraction f2al. 
Gershey et. al. (91) have detected a more pronounced methylation 
of lysine residues in immature erythrocytes than in the inactive 
mature cells. The association of methylation with the 
alterations in the chromosome structure preceding mitosis appear 
to involve these lysine residues. 
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Ga l lwitz (92), however, has identified two nuclear trans-
methylases from rat thymus, one of which (IIN) preferred histone 
f2al, while the other (IN) preferred histone f3 as a substrate. 
The major products were not methylated lysine residues, but arginine 
residues other than E-N-methyl arginine. Other groups 
(40,41,262,263) had previously shown that in contrast to those of 
rat thymus, calf thymus histones contained negligible amounts 
of these altered residues. 
Rat liver proteins were specifically (41) modified by cytoplasmic 
( 41, 93,261) "Methylase I" (261) yielding E-N-methyl arginine and 
a-N-methylguanidinomethyl arginine residues (40,88). Here 
the slightly lysine-rich fraction f2b was altered in advance 
of (63) and more than (41,262,263) the arginine-rich fractions 
f2al and f3. The activity of this enzyme was significantly 
diminished in estradiol 178-treated immature rats (41). Kaye 
et. al. (41) have proposed that this methylation of arginine 
residues takes place before the histones are transported to the 
nucleus, hence prior to their attachment to DNA. 
In addition to the above, a cytoplasmic "Methylase II" (93) 
transfers the methyl group to free carboxyl groups of various 
proteins, including histones. The enzyme catalyzing the 
formation of 3:methyl-histidine found in fowl erythrocytes (91) 
and Novikoff hepatoma (88) has not as yet been isolated. 
Our tests examined histone methylation on the basis of 
3 H-methionine incorporation (see 3.4.). Hydrocortisone 
effected JtO variation from control values until 6 hours after its 
-
administration, whereupon a 40% increase was noted (Figure 4.3.5., 
Table 4.2). Since both TAT activity and RNA synthesis had already 
reached a maximum at this time (4.1; 4.2) , . the enhanced methylation 
here may reflect the beginnings of reactions in the chromatin not 
directly related to the induction of enzyme synthesis. 
The injection of insulin, however, initiated a startling rise 
in methyl uptake within 2 hours; the increase was expanded 
after 4 hours to twice the control values, and at 6 hours still 
further to three times the control level (Figure 4. 3. 5. , Tab'le 4. 2) . 
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Figure 4. 3. 5. EFFECT OF HYDROCORTISONE AND INSULIN ON 
HISTONE METHYLATION 
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Figure 4. 3. 6. EFFECT OF HYDROCORTISONE AND INSULIN ON 
METHYLATION OF HCl EXTRACT PROTEINS 
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Reports on the methylation of all possible protein contaminants 
in histone preparations suggest that these are methylated to a 
much lesser extent (or not at all) than the histones themselves 
(40,88,89). Comparison of the 3 H-content of our HCl extracts 
and histone solutions (Figure 4.3.6., Table 4.2) indicate that the 
electrophoretically identified contaminants in the HCl extract 
(Figure 3.4b) were indeed labelled. 
Since low molecular weight RNA has been found in close 
association with the chromatin (142-146) and the methylation of 
tRNA (267) has been shown to increase at times of increased 
genetic activity (268,269), it was ne~essary to ensure that the 
content of radioactive methyl groups in our histone preparation 
was not due to contamination with RNA, but indeed to a genuine 
histone methylation. 
Methylated histone samples were therefore subjected to RNase 
to investigate the possible presence of contaminating RNA. 
Such samples proved to be unaffected by this enzyme (see methods 
3.3.4) indicating that the preparations were free of digestible 
RNA. 
Trypsin digestion of methylated histone resulted in the formation 
of labelled peptides and amino acids (high voltage electrophoresis 
and TCA precipitation - section 3.3.4). Acid hydrolysis of 
radioactive histone was followed by adsorption of the degraded 
peptides and amino acids onto Dowex 50 (X4) H+ ion exchanger. 
This yielded a water eluent devoid of radioactivity, and 100% 
recovery of the applied radioactivity in · the NH 40H eluent 
(see 3~. 4). 
The increased methylation seen after insulin administration was 
therefore indeed due to histone modification and not to tRNA 
methylation. 
Burdon and Pearce (79) have furnished evidence for a methylating 
enzyme present in - the chromatin of Krebs 2 ascites tumour cells 
(264) which modifies both histone and DNA. Kinetic studies 
implied that DNA methylation eventuated as a result of transfer 
of methyl groups from the histone lysyl residues (264,265). 
59. 
Cyclic AMP was found to be a specific stimulator of the 
modification reaction (79). Chromatin itself has both cyclase 
and cAMP phosphodiesterase activity and the latter is inhibited 
by low concentrations of certain hormones (79). Considering 
that cyclic AMP is known to be the secondary mediator of insulin 
action in vivo (79,276,266) it is tempting to relate our results 
concerning histone methylation in response to insulin, with the 
reaction described above (79). 
Paik and Kim (295) have compared the basic dissociation constants 
of E-amino groups of lysyl residues and their methyl substituted 
compounds. They report the basicity scale - N(CH 3 ) 2 > - NH2 
-NH(CH 3 ) >-(N(CH 3 ) 3 )+ in increasing order. 
Dirnethylation of 
> 
such lysyl residues would therefore have an opposite effect to 
that of trimethylated compounds. The dirnethylation could thus 
result in a decreased basicity and possibly affect the histone-DNA 
interaction in a manner similar to tnat of acetylation and 
phosphorylation. 
The highest m~thyla~e activity found in rat liver is that of the 
nuclear 'Methylase III' (295) which specifically modifies lysyl 
residues (260). If this substitution results in an increase of 
dirnethylated residues, it can be envisaged that the histone-DNA 
bonds are thereby weakened leading to an increased availability 
of the DNA for transcription. 
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5. DISCUSSION AND CONCLUSIONS : 
Various theories on the subject of the repression and depression 
of the genome have been considered in Section 1. The 
involvement of histones seems implicit although their exact 
role remains uncertain. Other components present in the chromatin 
appear to influence the nature of DNA-histone complexes thereby 
conferring specificity to the suppressive functions of these 
proteins. Modifications of histone amino acid side chains by 
acetylation, phosphorylation and methylation seem to be immanent 
processes in the regulation of their function. Varying structural 
alterations as response to the activation of cellular activity 
have been reported. Active chromatins have been noted to contain 
more acetylated (65,187,190,223) phosphorylated (37,38,65,190,270,271) 
and methylated (91,289) arginine-rich histones (65,91,190,223) than 
their inactive forms. Some workers deny this (272,273). 
Phytohemaglutinin-stimulated lymphocytes exhibit an early increase 
in RNA synthesis, - again, both positive (34,37,188,189,247,249) and 
negative (274) correlations with histone modifications have been 
described. k limited number of reports (123) refute such 
I 
structural variations in the course of liver regeneration (63,86, 
102,189,191,241,;242,255,275) after partial hepatectomy. With 
regard to these responses to either steroid (36,40,41,188,222,224) 
or polypeptide (36,68,76-78,251,254,274) hormonal influence, few 
authors agree. 
Notwithstanding, the consequence of gene activation is trans-
cription. Enhanced template activity of the chromatin (12-16) 
and increased activity of endogenous RNA polymerases in target 
cells, are well established results of hormonal treatment 
(2,6-8,32,110). The accompanying synthesis of RNA includes 
all types (162~163) - the initial precursor molecules, ribosomal 
(171-174), transfer (164,177) and DNA-like (173,174,219,221) 
attended by their matured 11 degradation products" (173-175). 
Partial hepatectomy (28,163) and steroid hormone administration 
(277,278) appear to cause an alteration in the distribution of 
RNA species; some workers have reported an increase in GC-rich 
species (28) (ribosomal (27) ) , others a multiplication of the 
AU-rich (DNA-like (27) ) species (163). 
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The ensueing protein synthesis is dependent on the synthesis 
and transport to the cytoplasm of rRNA, mRNA and tRNA. One 
point on which all researchers agree, is that RNA synthesis precedes 
hormone-induced protein synthesis. The present time course studies 
on the hepatic responses to hydrocortisone and insulin substantiate 
this, although the preceding events appear to differ with the two 
hormones. 
Accepting that our conditions of measurement had their limitations 
(see 4.3) we found that the effect of hydrocortisone encompassed 
but trivial variations in total histone modification. 
14 C-Acetate and 32 P incorporation showed minor changes early in 
the induction period, while 3 H-methionine incorporation remained 
at control levels until 6 hours after hormone administration, 
at which time there was a slight rise in methylation. 
RNA synthesis, however, was substantially enhanced. That of high 
molecular weight species reached a maximum within 4 hours. The 
low molecular weight species reached their maximum 6 hours after 
hormone injection (see 4.2) although the lOS region, which would 
contain mRNA (164,173,221) already showed a definite increase after 
2 hours. Concomitant with these events was the intensification of 
TAT activity to twice control values 4 hours, and four times control 
values 6 hours after the administration of hydrocortisone. 
The influence of insulin on TAT, in comparison with that of 
hydrocortisone, was slightly delayed - the extracts from injected 
animals retained control activities until the 4 hour period to.rise 
between 4 and 6 hours to a five-fold increase. The preceding 
----hist one ·modifications were, in contrast to those under hydrocortisone, 
conspicuously augmented by the presence of insulin. Our results 
confirm those of authors who have implied greater acetate and 
phosphate uptake in advance of RNA synthesis (36,65,188,190). 
Acetylation was shown to expand 30 minutes after hormone injection, 
and subside to control values for the remainder of the experimental 
period. Phosphorylation (whether it involved histone and/or 
NHC protein (see 4.3.2) proceeded by a similar pattern. Our 
observations regarding methylation were unexpected. The reports 
of Burdon et. al. (79) on stimulation of chromatin methylase 
activity by cyclic AMP and the fact that cyclic AMP is a secondary 
mediator in induction by insulin (276) could relate to the means 
by which this reaction was executed. 
64. 
Turner and Hancock (289) have reported a higher methylase activity in 
fetal liver extracts (i.e. with high cellular activity) than in 
adult liver extracts. Possiply the transmethylation reaction 
described by Pearce et. al. (264,265) by which methyl groups are 
transferred from histone to DNA would result in a release of protein 
from the DNA-histone complex . Since cyclic AMP (which specifically 
activates this reaction (79)) is a secondary mediator of insulin 
action (2 76) , ~.-our results could be a reflection of the first step 
in this transmethylation, resulting in increased transcription. 
If the increased methylation involved mostly dimethylation of 
~-amino groups of lysyl residues, it is possible that the decreased 
basicity resulting from such modification (295) would cause a 
weakening of the DNA-histone bonds and hence an increased availability 
of the DNA for transcription. 
Alte.rnatively, if the increased methylation involved mono- and/or 
trimethylation of such residues, the result would be a net 
enhancement-of-charge (63,295) and possibly a consolidation of the 
DNA-histone interaction (46). Insulin is known to repress the 
activity of certain hepatic enzymes (300-302). The enhanced 
methylation in this case could be an expression of a shutting-down 
mechanism for the purpose of repression. Therefore, although 
TAT activity be increased under the influence of insulin, other 
enzymes may well be repressed. 
Histone modification appeared to be an equivocal event in the 
steroid-induced amplification of RNA and protein synthesis. 
If histones be involved, their direct interaction with hormone 
(16,151,L.58) and/or regulatory proteins (12-14,279,280), with 
the RNA polymerase enzyme (50,51,57,281) or their modified 
associations with NHC proteins (35,105,115,134,140,247) are 
alternative mechanisms by which they may mediate induction by the 
steroid hormone. Translational level control (282,283) has also 
been described. On the other hand, the involvement of these 
structural modifications of histone in insulin induction is ratified 
by their distinctive response to this hormone. 
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In this investigation two different hormones have induced the same 
enzyme activity. The patterns of histone modification preceding 
and accompanying RNA and enzyme synthesis were, however, distinctly 
different. TAT activity is but one indicat or of increased 
transcriptional and translational activity in response to the 
two hormones. Each induces a number of enzymes. Therefore 
what may appear a qualitative difference in the modification of 
histones, could well be a quantitative difference in the number 
of enzymes induced by either insulin or hydrocortisone. 
Another explanation cannot be neglected, namely, that the two 
hormones trigger transcription in different ways. It can be 
envisaged that the gene for TAT exists either as a single copy 
or as several copies physically attached to different hormone 
receptors. Each of these receptors, on combination with the 
inducer, could initiate a different series of events leading to 
the same result, i.e. the exposure of the histone-covered gene 
to the DNA-dependent RNA polymerase. 
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SUMMARY 
The in vivo effects of hydrocortisone and insulin on histone 
modification (acetylation, phosphorylation and methylation), 
RNA and enzyme synthesis in rat liver have been investigated. 
1. Both hormones were found to induce tyrosine transaminase 
activity to between 4 and 5 times control values within 6 hours 
of their administration. 
2. RNA synthesis, involving all species, was increased within 
2 hours, the hrgh molecular weight species reaching a maximum at 
4 hours, and the lower molecular weight species reaching their 
maximum at 6 hours. 
3. Hydrocortisone effected minor alterations in histone 
modification - 14 C-acetate and 32 P incorporation showed slight 
changes early in the induction period, while 3 H-methionine 
incorporation remained at control levels until 6 hours after 
hormone administration at which stage there was a slight rise 
in methylation. 
4. Insulin injection resulted in significant increases of 
all three forms of histone modification. Acetylation and 
phosphorylation increased in advance of the enhanced RNA 
synthesis, while the rise in methylation continued almost 
linearly from 2 hours to 6 hours after administration of the 
polypeptide hormone. 
The different means by which hydrocortisone and insulin 
----
a cc om pl is h their inductive effects is briefly discussed. 
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